Clinical Trial Update: Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates a Phase 2/Phase 3 study is examining how genetic variations influence nalbuphine's effectiveness for postoperative pain, curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Nalbuphine (Nubain) (nalbuphine)

Snippet

Sponsor: Dr. Asma Abdus Salam | Conditions: Cholecystectomy, Hernia, Abdominal | Phase 2, Phase 3 | Status: RECRUITING